TOKYO, May 12 (Pulse News Wire) – AuBEX Corporation (3583.T) reported flat revenue and declining profits for the fiscal year ended March 31, 2026. Revenue remained unchanged at ¥70 billion, while operating profit was ¥10 million, down from the previous year.
Despite a slight slowdown in sales for its pen tip products, medical device sales continued to grow steadily. However, higher costs and lower high-value product sales led to reduced profitability across segments. In the technology division, sales growth slowed during the latter half of the fiscal year, impacting overall performance. Conversely, cosmetic pen tips showed signs of recovery.
Medical devices maintained strong sales momentum due to aggressive marketing efforts at international exhibitions and conferences. Looking ahead, the company's long-term vision includes enhancing the development of high-value products and expanding into new markets. However, uncertainties related to Middle East geopolitical conditions make it difficult to forecast future performance accurately. As such, the company has yet to release detailed earnings forecasts for the next fiscal year.
🔴 Confidence: Review recommended AI-translated content.